188 related articles for article (PubMed ID: 15070602)
1. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors.
Durkin AJ; Bloomston M; Yeatman TJ; Gilbert-Barness E; Cojita D; Rosemurgy AS; Zervos EE
J Am Coll Surg; 2004 Nov; 199(5):724-31. PubMed ID: 15501112
[TBL] [Abstract][Full Text] [Related]
3. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
Crnogorac-Jurcevic T; Gangeswaran R; Bhakta V; Capurso G; Lattimore S; Akada M; Sunamura M; Prime W; Campbell F; Brentnall TA; Costello E; Neoptolemos J; Lemoine NR
Gastroenterology; 2005 Nov; 129(5):1454-63. PubMed ID: 16285947
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression in patients genetically predisposed to pancreatic cancer.
Zervos EE; Tanner SM; Osborne DA; Bloomston M; Rosemurgy AS; Ellison EC; Melvin WS; de la Chapelle A
J Surg Res; 2006 Oct; 135(2):317-22. PubMed ID: 16815451
[TBL] [Abstract][Full Text] [Related]
7. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes].
Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
[TBL] [Abstract][Full Text] [Related]
9. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
11. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
[TBL] [Abstract][Full Text] [Related]
12. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
[TBL] [Abstract][Full Text] [Related]
13. GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for real-time PCR.
Kidd M; Nadler B; Mane S; Eick G; Malfertheiner M; Champaneria M; Pfragner R; Modlin I
Physiol Genomics; 2007 Aug; 30(3):363-70. PubMed ID: 17456737
[TBL] [Abstract][Full Text] [Related]
14. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC
J Gastroenterol Hepatol; 2005 Feb; 20(2):256-63. PubMed ID: 15683429
[TBL] [Abstract][Full Text] [Related]
15. The expression of the carboxyl ester lipase gene in pancreas and pancreatic adenocarcinomas.
Reuss R; Aberle S; Klingel K; Sauter M; Greschniok A; Franke FE; Padberg W; Blin N
Int J Oncol; 2006 Sep; 29(3):649-54. PubMed ID: 16865281
[TBL] [Abstract][Full Text] [Related]
16. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
17. Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin.
Dennis JL; Vass JK; Wit EC; Keith WN; Oien KA
Cancer Res; 2002 Nov; 62(21):5999-6005. PubMed ID: 12414618
[TBL] [Abstract][Full Text] [Related]
18. The gamma-aminobutyric acid A receptor pi subunit is overexpressed in pancreatic adenocarcinomas.
Johnson SK; Haun RS
JOP; 2005 Mar; 6(2):136-42. PubMed ID: 15767729
[TBL] [Abstract][Full Text] [Related]
19. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Wang H; Han H; Von Hoff DD
Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
[TBL] [Abstract][Full Text] [Related]
20. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
